1. Home
  2. CADL vs SBGI Comparison

CADL vs SBGI Comparison

Compare CADL & SBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$12.87

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Sinclair Inc.

SBGI

Sinclair Inc.

HOLD

Current Price

$13.79

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
SBGI
Founded
1999
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
CADL
SBGI
Price
$12.87
$13.79
Analyst Decision
Strong Buy
Buy
Analyst Count
7
5
Target Price
$19.00
$22.00
AVG Volume (30 Days)
1.2M
486.6K
Earning Date
05-14-2026
04-30-2026
Dividend Yield
N/A
6.56%
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
$3,169,000,000.00
Revenue This Year
N/A
$12.37
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$12.46
52 Week High
$14.00
$17.88

Technical Indicators

Market Signals
Indicator
CADL
SBGI
Relative Strength Index (RSI) 59.95 45.17
Support Level $4.84 $13.13
Resistance Level N/A $14.48
Average True Range (ATR) 0.89 0.45
MACD 0.01 -0.05
Stochastic Oscillator 68.23 1.40

Price Performance

Historical Comparison
CADL
SBGI

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About SBGI Sinclair Inc.

Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay TV distributors.

Share on Social Networks: